9 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with lung-rockets ... B profile is a half ... , a half B-profile ... www.grepmed.com/images/11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
Local Anaesthetic Toxicity - Guidelines for Crises in Anaesthesia
Signs of severe toxicity:
 • Sudden alteration in
- Guidelines for ... infusion pumps). ❷ Call ... of problem. ❸ Call ... ensure adequate lung ... Diagnosis #Management #Workup
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... Direct cytotoxic lung ... • Amiodarone half ... Dyspnea 3. ... #Toxicity #Pulmonary
Intraoperative Laryngospasm and Stridor - Guidelines for Crises in Anaesthesia

❶ Call for help and inform theatre
and Stridor - Guidelines ... Anaesthesia ❶ Call ... over-vigorous attempts at lung ... negative-pressure pulmonary ... Diagnosis #Management #Workup
Polycythemia - Differential Diagnosis Algorithm
Polycythemia itself isn’t a diagnosis. Like many things, it is a condition
Differential Diagnosis Algorithm ... Better call hematology ... , this list is long ... you’ll do a good workup ... #workup #hematology
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... #Algorithm #Effusion ... Management #Pleural #Pulmonary
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... cardiovascular or pulmonary ... risk of organ toxicity ... Network (NCCN) guidelines ... #algorithm #hematology